March 29, 2026 Cases of 'white plague' rising in US as doctors warn of 'rebound effect' Tuberculosis, also known as "the white plague," is rising in the U.S. post-pandemic, with over 10,600 cases confirmed in 2024, the CDC reports.
March 28, 2026 Hormone therapy boosts weight loss drug results by 35% in women, study finds A Mayo Clinic study suggests postmenopausal women lost 35% more weight combining hormone therapy with tirzepatide, though experts urge caution on the findings.
March 24, 2026 New stronger weight-loss drug gets green light from FDA: 'Major jump' The FDA approved Wegovy HD, a higher-dose semaglutide for weight loss in adults with obesity, offering greater weight reduction, as experts warn of side effects.
March 24, 2026 Stopping GLP-1 drugs like Ozempic erodes heart health benefits quickly, new study finds Stopping GLP-1 drugs like Ozempic quickly erodes heart protection, with two years off the medication raising cardiovascular risk by 22%, a new study finds.
March 20, 2026 Needle-free diabetes management could be on the horizon, study suggests Researchers in Japan developed an oral insulin pill that lowered blood sugar in diabetic mice, offering hope for a non-invasive alternative to injections.
March 18, 2026 Stopping Ozempic? New study reveals surprising weight regain results after GLP-1s New research challenges fears about Ozempic weight regain. Cleveland Clinic study of 8,000 patients finds minimal rebound after stopping GLP-1 medications.
March 17, 2026 Adult ADHD stimulant prescriptions are surging, and doctors are raising concerns Adult ADHD treatment has surged with stimulant prescriptions more than doubling since the COVID-19 pandemic began. A new study reveals a dramatic healthcare trend.
March 14, 2026 I was a doctor caring for Alzheimer’s patients. At 57, I became one. Here’s what’s next Internal medicine doctor diagnosed with Alzheimer's at 57 shares how monoclonal antibody treatment restored his cognitive function and quality of life.
March 13, 2026 Why Ozempic users are actually spending more on high-end chocolate A new report from Lindt & Sprüngli suggests households using GLP-1 weight-loss medications are driving stronger growth in premium chocolate sales, even as some research shows overall food spending declines.
March 9, 2026 Cannabis compounds could reverse disease affecting one-third of adults Compounds found in cannabis could provide a new roadmap for treating the world’s most common chronic liver disorder, according to a study released by the Hebrew University of Jerusalem.